ISSN: 1473-7140

Journal Home

Journal Guideline

Expert Review of Anticancer Therapy Q2 Unclaimed

Taylor and Francis Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Expert Review of Anticancer Therapy is a journal indexed in SJR in Oncology and Pharmacology (medical) with an H index of 79. It has a price of 4000 €. It has an SJR impact factor of 0,841 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,841.

Expert Review of Anticancer Therapy focuses its scope in these topics and keywords: cancer, advanced, lung, breast, therapy, metastatic, chemotherapy, colorectal, gastrointestinal, mortality, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Oncology (Q2) Pharmacology (medical) (Q2)

Price

4000 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,841

SJR Impact factor

79

H Index

125

Total Docs (Last Year)

346

Total Docs (3 years)

9386

Total Refs

1050

Total Cites (3 years)

306

Citable Docs (3 years)

2.74

Cites/Doc (2 years)

75.09

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Frontiers in Oncology Q2
International Journal of Oncology Q2
Cancer Epidemiology Q2
Translational Lung Cancer Research Q2
Familial Cancer Q2

Compare this journals